Epigenomics has named Richard Wender to the company’s medical advisory board for colorectal cancer screening.
Interleukin Genetics has appointed Lewis Bender to the post of CEO. Bender has been involved in biotechnology for over 15 years as a senior executive, including holding the post of senior VP of business development and VP of manufacturing and CTO at Emisphere Technologies.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
